Phosphoinositide-dependent kinase 1 controls migration and malignant transformation but not cell growth and proliferation in PTEN-null lymphocytes
暂无分享,去创建一个
David K. Finlay | Linda V. Sinclair | Carmen Feijoo | Caryll M. Waugh | Thijs J. Hagenbeek | Hergen Spits | Doreen A. Cantrell | D. Cantrell | H. Spits | L. Sinclair | D. Finlay | C. Feijóo | C. Waugh | Thijs J Hagenbeek
[1] M. Varella‐Garcia,et al. Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation , 2008, Nature.
[2] J. Mendell. miRiad Roles for the miR-17-92 Cluster in Development and Disease , 2008, Cell.
[3] J. Dixon,et al. PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease. , 2002, Trends in cell biology.
[4] M. Birnbaum,et al. Akt1 and Akt2 are required for αβ thymocyte survival and differentiation , 2007, Proceedings of the National Academy of Sciences.
[5] A. Ferrando,et al. NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL. , 2008, Blood.
[6] M. Okabe,et al. Functional competence of T cells in the absence of glycosylphosphatidylinositol‐anchored proteins caused by T cell‐specific disruption of the Pig‐agene , 1998, European journal of immunology.
[7] Cornelis J. Weijer,et al. PtdIns(3,4,5)P3-Dependent and -Independent Roles for PTEN in the Control of Cell Migration , 2007, Current Biology.
[8] Lisa M. Ebert,et al. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. , 2005, Molecular immunology.
[9] B. Burgering,et al. A brief introduction to FOXOlogy , 2008, Oncogene.
[10] E. Wolf,et al. CCR7 Coordinates the Primary Immune Response by Establishing Functional Microenvironments in Secondary Lymphoid Organs , 1999, Cell.
[11] R. Lahesmaa,et al. The RhoA transcriptional program in pre-T cells , 2007, FEBS letters.
[12] D. Alessi,et al. The serine kinase phosphoinositide-dependent kinase 1 (PDK1) regulates T cell development , 2004, Nature Immunology.
[13] T. H. van der Kwast,et al. Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis. , 2005, Cancer research.
[14] C. Thompson,et al. Akt-dependent transformation: there is more to growth than just surviving , 2005, Oncogene.
[15] D. Alessi,et al. Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia , 2003, The EMBO journal.
[16] S. Morrison,et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells , 2006, Nature.
[17] Jing Wang,et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes , 2008, Nature Immunology.
[18] L. Cantley,et al. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[19] Thijs J. Hagenbeek,et al. The Loss of PTEN Allows TCR αβ Lineage Thymocytes to Bypass IL-7 and Pre-TCR–mediated Signaling , 2004, The Journal of experimental medicine.
[20] David K. Finlay,et al. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking , 2008, Nature Immunology.
[21] A. Berns,et al. PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum. , 2002, Development.
[22] T. Ludwig,et al. Unequal Contribution of Akt Isoforms in the Double-Negative to Double-Positive Thymocyte Transition1 , 2007, The Journal of Immunology.
[23] R. Deberardinis,et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.
[24] C. Nobes,et al. Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways , 1996, Current Biology.
[25] Kathryn A. O’Donnell,et al. Activation of Transferrin Receptor 1 by c-Myc Enhances Cellular Proliferation and Tumorigenesis , 2006, Molecular and Cellular Biology.
[26] V. Lazar,et al. FOXO1 Regulates L-Selectin and a Network of Human T Cell Homing Molecules Downstream of Phosphatidylinositol 3-Kinase1 , 2008, The Journal of Immunology.
[27] V. Stewart,et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement , 1992, Cell.
[28] T. Sasaki,et al. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. , 2001, Immunity.
[29] J. Mora,et al. T-cell homing specificity and plasticity: new concepts and future challenges. , 2006, Trends in immunology.
[30] H. Degrendele,et al. Requirement for CD44 in activated T cell extravasation into an inflammatory site. , 1997, Science.
[31] J. Cyster,et al. Finding a way out: lymphocyte egress from lymphoid organs , 2007, Nature Immunology.
[32] J. Rathmell,et al. Glucose Uptake Is Limiting in T Cell Activation and Requires CD28-Mediated Akt-Dependent and Independent Pathways1 , 2008, The Journal of Immunology.
[33] D. Alessi,et al. New anti-cancer role for PDK1 inhibitors: preventing resistance to tamoxifen. , 2009, The Biochemical journal.
[34] S. Armstrong,et al. FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress , 2007, Cell.
[35] E. Sebzda,et al. Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns , 2008, Nature Immunology.
[36] J. Dick,et al. Targeting of CD44 eradicates human acute myeloid leukemic stem cells , 2006, Nature Medicine.
[37] L. Cantley,et al. PI3K pathway alterations in cancer: variations on a theme , 2008, Oncogene.
[38] Corey M. Carlson,et al. Kruppel-like factor 2 regulates thymocyte and T-cell migration , 2006, Nature.
[39] A. Hall,et al. Regulation of Cell Migration by the C2 Domain of the Tumor Suppressor PTEN , 2004, Science.
[40] W. Sellers,et al. Drug discovery approaches targeting the PI3K/Akt pathway in cancer , 2008, Oncogene.
[41] R. Parsons,et al. Hypomorphic Mutation of PDK1 Suppresses Tumorigenesis in PTEN+/− Mice , 2005, Current Biology.
[42] B. Hemmings,et al. Deletion of PKBα/Akt1 Affects Thymic Development , 2007, PloS one.
[43] S. Ward. Faculty Opinions recommendation of Phosphatidylinositol 3-kinase regulates thymic exit. , 2005 .
[44] C. Thompson,et al. Activated Akt promotes increased resting T cell size, CD28‐independent T cell growth, and development of autoimmunity and lymphoma , 2003, European journal of immunology.
[45] Yonghong Xiao,et al. FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis , 2007, Cell.
[46] J. Cyster,et al. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. , 2005, Annual review of immunology.
[47] W. Paul,et al. Neonates support "homeostatic" proliferation. , 2002, Advances in experimental medicine and biology.
[48] T. Mak,et al. Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice , 2008, Proceedings of the National Academy of Sciences.
[49] Ximing J. Yang,et al. The deficiency of Akt1 is sufficient to suppress tumor development in Pten mice , 2006 .
[50] M. Birnbaum,et al. Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation. , 2007, Proceedings of the National Academy of Sciences of the United States of America.
[51] R. A. Etten,et al. Requirement for CD44 in homing and engraftment of BCR-ABL–expressing leukemic stem cells , 2006, Nature Medicine.
[52] L. Turka,et al. Cutting Edge: T Cell Requirement for CD28 Costimulation Is Due to Negative Regulation of TCR Signals by PTEN1 , 2006, The Journal of Immunology.
[53] Thijs J. Hagenbeek,et al. T-cell lymphomas in T-cell-specific Pten-deficient mice originate in the thymus , 2008, Leukemia.
[54] K. Ley,et al. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. , 1994, Immunity.
[55] K. Okkenhaug,et al. PI3K-signalling in B- and T-cells: insights from gene-targeted mice. , 2001, Biochemical Society transactions.
[56] R. Mamillapalli,et al. Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases , 2000, Current Biology.
[57] David K. Finlay,et al. Notch-induced T cell development requires phosphoinositide-dependent kinase 1 , 2007, The EMBO journal.
[58] D. Cantrell,et al. Inhibition of Rho at different stages of thymocyte development gives different perspectives on Rho function , 1999, Current Biology.
[59] Jianzhu Chen,et al. Krüppel-Like Factor 2 Controls T Cell Trafficking by Activating L-Selectin (CD62L) and Sphingosine-1-Phosphate Receptor 1 Transcription1 , 2007, The Journal of Immunology.
[60] Ximing J. Yang,et al. The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/- mice. , 2006, Genes & development.
[61] Linda V. Sinclair,et al. Differential regulation of T-cell growth by IL-2 and IL-15. , 2006, Blood.
[62] Daniel R. Beisner,et al. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor , 2009, Nature Immunology.
[63] M. Ciofani,et al. Notch promotes survival of pre–T cells at the β-selection checkpoint by regulating cellular metabolism , 2005, Nature Immunology.
[64] T. Mak,et al. Portrait of PTEN: Messages from mutant mice , 2008, Cancer science.